Miami Marlins pitcher Paul Campbell, who made the first start of his career on Saturday, received an 80-game suspension from Major League Baseball on Monday for violating its performance-enhancing drug policy.
Campbell, 25, who made his major league debut April 3, tested positive for dehydrochlormethyltestosterone (DHCMT), according to MLB, and will be suspended without pay.
DHCMT-related suspensions have become a significant point of contention for major- and minor-league players, with some drug experts questioning the efficacy of the tests for a PED that has not been in vogue in doping circles since the East Germans developed the steroid in the 1970s and '80s.
Washington Nationals catcher Tres Barrera in August 2020 sued MLB, the commissioner’s office, the director of an anti-doping lab and two league-contracted labs in Utah and Montreal after he tested positive for DHCMT and was suspended. After Barrera's positive test, Jeff Novitzky, the former federal agent credited with breaking open the BALCO doping scandal and now a consultant for UFC, tweeted that there was "something screwy" with DHCMT test results.
Barrera dropped his lawsuit after his suspension was reduced to the entirety of the 60-game 20
Source: Read Full Article